Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Using Long-Acting Injectable Buprenorphine in Addiction Treatment

July 13, 2023
3:00 pm–4:00 pm ET

This one-hour training prepares nurses and other medical professionals to use long-acting injectable buprenorphine (Sublocade) in addiction treatment.

Register now

Virtual meeting

Via Zoom

Description

This is a one-hour training that prepares nurses offering medication for opioid-use disorder to manage addiction treatment with long-acting injectable buprenorphine. Topics covered will include: the pharmacology of long-acting injectable buprenorphine; patient selection; medication storage and administration; clinical logistics; side effects; supplemental dosing; lessons learned from the field; and billing and specialty pharmacies. We will also have an open discussion to learn from each other’s experiences with using this treatment.

This training will be held via Zoom. We would prefer that you log in using a device with a webcam so that we can all connect via video. Individuals who are registered and attend the entire duration of the course will receive a copy of the materials at the conclusion of the training.

Intended audience

Attendance is required for all OBAT nurses and MAs who work in a DPH/BSAS funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend.

Speakers

Brittany L. Carney, DNP, FNP-BC (she/her) Jessica Kemp, RN, CARN (she/her)

Objectives

By the end of the training, participants will have the knowledge necessary to:

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Boston Medical Center grants 1.00 hours to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of nursing continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 general continuing education credits.

Boston Medical Center grants 1.00 hour, 1.00 of which are classified as pharmacology hours, to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of nursing continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 1.00 contact hours will be offered to participants who attend the training and complete the evaluation.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.


© 2024 Boston Medical Center. All rights reserved. Site by Root802.